Cytometry Part B: Clinical Cytometry features original research reports, in-depth reviews and special issues that directly relate to and palpably impact clinical flow, mass and image-based cytometry. These may include clinical and translational investigations important in the diagnostic, prognostic and therapeutic management of patients. Thus, we welcome research papers from various disciplines related [but not limited to] hematopathologists, hematologists, immunologists and cell biologists with clinically relevant and innovative studies investigating individual-cell analytics and/or separations. In addition to the types of papers indicated above, we also welcome Letters to the Editor, describing case reports or important medical or technical topics relevant to our readership without the length and depth of a full original report.
A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients
来源期刊:Cytometry Part B: Clinical CytometryDOI:10.1002/cyto.b.21831
A modified flow cytometry method for objective estimation of human CD4+ regulatory T cells (CD4+ Tregs) in peripheral blood, via CD4/CD25/CD45RO/FoxP3 labeling
来源期刊:Cytometry Part B: Clinical CytometryDOI:10.1002/cyto.b.21841
A Novel Rapid Method of Red Blood Cell and Platelet Permeabilization and Staining for Flow Cytometry Analysis
来源期刊:Cytometry Part B: Clinical CytometryDOI:10.1002/cyto.b.21839
Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma
来源期刊:Cytometry Part B: Clinical CytometryDOI:10.1002/cyto.b.21833
Applications of imaging flow cytometry in the diagnostic assessment of red cell membrane disorders
来源期刊:Cytometry Part B: Clinical CytometryDOI:10.1002/cyto.b.21857